Joseph Pace, Consultant Dermatologist
Andreas Blum, Assistant Professor of Dermatology, University of Tuebingen, Germany
Bernard Coleiro, Division of Rheumatology, Department of Internal Medicine, Mater Dei Hospital, Malta
Behçet’s syndrome is a condition characterised by different clinical manifestations including the commonly occurring recurrent mouth aphthae as well as other less common features. When the latter features are the predominant form of presentation this may pose a diagnostic challenge. Treatment for Behcet’s disease may also be problematic as patients may fail to respond to immunosuppressive therapy. This presentation will discuss some of the challenges involved in the diagnosis and treatment of Behçet’s disease.
Catalin Popescu, Associate Professor of Dermatology, Carol Davila University of Medicine, Bucharest, Romania
Isotretinoin has dramatically changed the lives of patients with nodulo-cystic acne. In low dose it is also very effective in less severe acne cases, in which other therapies have failed to achieve long-term remission. However, isotretinoin is frequently underutilised due to fears of rare but severe adverse effects such as depression, suicide and inflammatory bowel disease. Are these fears justified? What is the best available evidence regarding these risks? How should they be managed?
Frontal fibrosing alopecia (FFA) describes hair loss and scarring characterised by progressive frontotemporal hair line recession.